These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 8200011

  • 41. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
    Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM.
    Circulation; 2003 Dec 02; 108(22):2751-6. PubMed ID: 14638544
    [Abstract] [Full Text] [Related]

  • 42. [Effects of simvastatin on blood levels of lipoprotein (a)].
    Galetta F, Sampietro T, Basta G, Giannasi G, Bionda A.
    Minerva Med; 1995 Dec 02; 86(7-8):299-303. PubMed ID: 7478073
    [Abstract] [Full Text] [Related]

  • 43. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
    Masana L, Mata P, Gagné C, Sirah W, Cho M, Johnson-Levonas AO, Meehan A, Troxell JK, Gumbiner B, Ezetimibe Study Group.
    Clin Ther; 2005 Feb 02; 27(2):174-84. PubMed ID: 15811480
    [Abstract] [Full Text] [Related]

  • 44. [The Scandinavian Simvastatin Survival Study: the clinical consequences].
    Larsen ML.
    Rev Esp Cardiol; 1995 Feb 02; 48 Suppl 5():39-42. PubMed ID: 7494939
    [Abstract] [Full Text] [Related]

  • 45. [Simvastatin in the treatment of hypercholesterolemia in the aged. An epidemiological and clinical study].
    Tamburrini LR.
    Minerva Med; 1992 Jun 02; 83(6):347-53. PubMed ID: 1630695
    [Abstract] [Full Text] [Related]

  • 46. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
    Darioli R, Bovet P, Brunner HR, Bercher L.
    Schweiz Med Wochenschr; 1990 Jan 27; 120(4):85-91. PubMed ID: 2305221
    [Abstract] [Full Text] [Related]

  • 47. Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease.
    Nordøy A.
    Minerva Med; 2002 Oct 27; 93(5):357-63. PubMed ID: 12410168
    [Abstract] [Full Text] [Related]

  • 48. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J, Oette K, Burrichter H.
    Fortschr Med; 1990 Feb 10; 108(4):71-2, 75-6. PubMed ID: 2312032
    [Abstract] [Full Text] [Related]

  • 49. [Mid-term clinical study of the effectiveness of and tolerability to simvastatin ++ in dyslipidemic patients].
    Irace L, Aiello C, Papa A, Sannino A, Petraglia L, De Lucia R, Dragonetti C.
    Minerva Med; 1992 Dec 10; 83(12):815-8. PubMed ID: 1491761
    [Abstract] [Full Text] [Related]

  • 50. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM, Jones PH, Adamczyk MA, Cain VA, Bryzinski BS, Blasetto JW, STELLAR Study Group.
    Curr Med Res Opin; 2003 Dec 10; 19(8):689-98. PubMed ID: 14687438
    [Abstract] [Full Text] [Related]

  • 51. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
    Feldman T, Koren M, Insull W, McKenney J, Schrott H, Lewin A, Shah S, Sidisin M, Cho M, Kush D, Mitchel Y.
    Am J Cardiol; 2004 Jun 15; 93(12):1481-6. PubMed ID: 15194017
    [Abstract] [Full Text] [Related]

  • 52. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L, Shah A, Davies MJ, Rotonda J, Maccubbin D, Tribble D, Veltri E, Mitchel Y.
    Curr Med Res Opin; 2006 May 15; 22(5):823-35. PubMed ID: 16709304
    [Abstract] [Full Text] [Related]

  • 53. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov 15; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 54. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.
    J Am Coll Cardiol; 2008 Apr 22; 51(16):1564-72. PubMed ID: 18420099
    [Abstract] [Full Text] [Related]

  • 55. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
    Caruzzo C, Uslenghi E, Varbella F, Caruzzo E, Marcolongo M, Brusca A.
    Minerva Cardioangiol; 1989 Dec 22; 37(12):509-15. PubMed ID: 2695857
    [Abstract] [Full Text] [Related]

  • 56. Long-term effects of simvastatin in hypercholesterolemic patients with NIDDM and additional atherosclerotic risk factors. Hyogo Simvastatin Study Group.
    Kazumi T, Yoshino G, Ohki A, Matsuba K, Ino T, Amano M, Kasuga M.
    Horm Metab Res; 1995 May 22; 27(5):239-43. PubMed ID: 7642176
    [Abstract] [Full Text] [Related]

  • 57. [Hypercholesterolemia: therapeutic approach].
    Alessandri C, Peverini F.
    Clin Ter; 1991 Jun 30; 137(6):373-97. PubMed ID: 1832610
    [Abstract] [Full Text] [Related]

  • 58. Effect of simvastatin in CAPD patients with hypercholesterolemia.
    De Vecchi A, Scalamogna A, Paparella M, Colombini M, Rovellini A, Pini C, Castelnovo C.
    Adv Perit Dial; 1992 Jun 30; 8():331-3. PubMed ID: 1361817
    [Abstract] [Full Text] [Related]

  • 59. [Maximal therapy of hypercholesterolemia in coronary heart disease].
    Thiery J, Armstrong V, Bosch T, Eisenhauer T, Schuff-Werner P, Seidel D.
    Ther Umsch; 1990 Jun 30; 47(6):520-9. PubMed ID: 2375008
    [Abstract] [Full Text] [Related]

  • 60. [Effects of simvastatin on plasma lipoproteins].
    Alessandri C, Basili S, Maurelli M, Andreozzi P, Bracaglia D, Cordova C.
    Clin Ter; 1994 Jan 30; 144(1):3-9. PubMed ID: 8168349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.